Most recent by Angela Duff Hogan, MD, FAAAAI, FACAAI, FAAP
Q&A: Asthma patients have options as GSK moves Flovent to generic production
GSK has stopped manufacturing its Flovent HFA and Flovent Diskus fluticasone propionate inhalers for asthma and has made authorized identical generic versions of these devices available instead.
AIRQ may better identify patients with current, future asthma morbidity
Patients, physicians and the symptom-based Asthma Control Test overestimate asthma control, but the Asthma Impairment and Risk Questionnaire does not, according to a study published in Annals of Allergy, Asthma & Immunology.
Mouse allergen exposure associated with air trapping among urban children with asthma
Exposure to mouse allergen was associated with air trapping but not with airflow limitation in a low-income, urban pediatric asthma population, according to a study published in The Journal of Allergy and Clinical Immunology.
Asthma diagnosis rates fall among children during COVID-19 pandemic
The numbers of new cases of childhood asthma significantly fell during the COVID-19 pandemic in Japan, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.
Asthma, respiratory allergy rates show decreasing trend among US children
Rates of asthma and respiratory allergy among children decreased from 2007 to 2018, with variations based on race, ethnicity, income level and other demographics, according to a study published in Annals of Allergy, Asthma & Immunology.
Viral infection common, leads to more acute symptoms in children with uncontrolled asthma
Children with uncontrolled asthma who visited the ED had a higher frequency of viral infections and more acute symptoms than children with controlled asthma, according to a study published in Annals of Allergy, Asthma & Immunology.